RPHM - Reneo Pharmaceuticals, Inc. Stock Price, Fair Value and News

$15.990.00 (0.00%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

RPHM Price Action

Last 7 days

-5.6%

Last 30 days

-7.5%

Last 90 days

7.1%

Trailing 12 Months

-72.8%

RPHM RSI Chart

RPHM Valuation

Market Cap

53.5M

Price/Earnings (Trailing)

-3.02

Price/Free Cashflow

-2.74

RPHM Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

RPHM Fundamentals

RPHM Earnings

Earnings (TTM)

-17.7M

Earnings Growth (Yr)

80.77%

Earnings Growth (Qtr)

73.89%

RPHM Profitability

Return on Equity

-23.96%

Return on Assets

-22.84%

Free Cashflow Yield

-36.48%

RPHM Investor Care

Buy Backs (1Y)

1.29%

Diluted EPS (TTM)

35.78

Revenue & Growth

About Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Its lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.

CEO	Mr. Gregory J. Flesher
WEBSITE	https://reneopharma.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	51

Reneo Pharmaceuticals, Inc. Frequently Asked Questions

What is the ticker symbol for Reneo Pharmaceuticals, Inc.? What does RPHM stand for in stocks?

RPHM is the stock ticker symbol of Reneo Pharmaceuticals, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Reneo Pharmaceuticals, Inc. (RPHM)?

As of Thu Nov 21 2024, market cap of Reneo Pharmaceuticals, Inc. is 53.46 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of RPHM stock?

You can check RPHM's fair value in chart for subscribers.

Is Reneo Pharmaceuticals, Inc. a good stock to buy?

The fair value guage provides a quick view whether RPHM is over valued or under valued. Whether Reneo Pharmaceuticals, Inc. is cheap or expensive depends on the assumptions which impact Reneo Pharmaceuticals, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RPHM.